Condition: Lung Cancer Prevention · Sponsor: Hospices Civils de Lyon
Lung cancer screening using low-dose CT (LDCT) has been shown to reduce mortality in high-risk populations. In 2022, the French National Cancer Institute (INCa) issued guidelines recommending screening for individuals aged 50-74 with a history of heavy smoking, including current smokers or those who quit less than 15 years ago. A national pilot program (IMPULSION) will be launched in 2025. Lung cancer incidence is strongly correlated with socioeconomic status, yet underserved populations remain difficult to engage in screening programs. Mobile health units using a "reach-out" strategy have demonstrated effectiveness in other countries (UK, Brazil, USA). In France, this approach has been used for breast cancer screening via mobile mammography units. The MobILYAD project aims to compare two screening modalities- a mobile demedicalized unit (CT-equipped van with trained nurses) and a conventional hospital-based unit- to assess the effectiveness of mobile screening in reaching socially disadvantaged populations.
This description comes directly from the study's public registry record.
Sébastien COURAUD, Pr · 04 78 86 44 01 · sebastien.couraud@chu-lyon.fr
Julie DE-BELMONT · 0478866698 · Julie.de-bermont@chu-lyon.fr
Always discuss trial participation with your own doctor first.
| " Centre de dépistage mobile " - Hôpital Lyon Sud | Pierre-Bénite, France | Recruiting |
| Service de Pneumologie " Centre de dépistage non mobile " - Hôpital Lyon Sud | Pierre-Bénite, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07015151